# ENDARI
> **NDA208587** · New Drug Application · Sponsor: EMMAUS MEDCL · Approved 2017-07-07
## Drug
- **FDA Application Number:** NDA208587
- **Application type:** New Drug Application
- **Brand name:** ENDARI
- **Generic name:** GLUTAMINE
- **Active ingredients:** L-GLUTAMINE
- **Dosage form:** FOR SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** EMMAUS MEDCL
- **Manufacturer:** Emmaus Medical, Inc.
- **First approval:** 2017-07-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208587)
---
*AI Analytics · CC0 1.0*